{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:33:35Z","timestamp":1790818415734,"version":"4.1.0"},"reference-count":79,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>MicroRNAs (miRNAs) are small non-coding RNA molecules that play a role in cancer linked to the regulation of important cellular processes and pathways involving tumorigenesis, cell proliferation, differentiation, and apoptosis. A lot of human miRNA sequences have been identified which are linked to cancer pathogenesis. MicroRNAs, in prostate cancer (PC), play a relevant role as biomarkers, show a specific profile, and have been used as therapeutic targets. Prostate cancer (PC) is the most frequently diagnosed cancer in men. Clinical diagnoses among the gold standards for PC diagnosis and monitoring are prostate-specific antigen (PSA) testing, digital rectal examination, and prostate needle biopsies. PSA screening still has a large grey area of patients, which leads to overdiagnosis. Therefore, new biomarkers are needed to improve existing diagnostic tools. The miRNA expression profiles from tumour versus normal tissues are helpful and exhibit significant differences not only between cancerous and non-cancerous tissues, but also between different cancer types and subtypes. In this review, we focus on the role of miRNAs-145, 148, and 185 and their correlation with stem cells in prostate cancer pathogenesis. MiR-145, by modulating multiple oncogenes, regulates different cellular processes in PC, which are involved in the transition from localised to metastatic disease. MiR-148 is downregulated in high-grade tumours, suggesting that the miR-148-3 family might act as tumour suppressors in PC as a potential biomarker for detecting this disease. MiR-185 regulation is still unclear in being able to regulate tumour processes in PC. Nevertheless, other authors confirm the role of this miRNA as a tumour suppressor, suggesting its potential use as a suitable biomarker in disease prognosis. These three miRNAs are all involved in the regulation of prostate cancer stem cell behaviour (PCSCs). Within this contest, PCSCs are often involved in the onset of chemo-resistance in PC, therefore strategies for targeting this subset of cells are strongly required to control the disease. Hence, the relationship between these two players is interesting and important in prostate cancer pathogenesis and in PCSC stemness regulation, in the attempt to pave the way for novel therapeutic targets in prostate cancer.<\/jats:p>","DOI":"10.3390\/ijms23031626","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T01:46:08Z","timestamp":1643593568000},"page":"1626","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-0490","authenticated-orcid":false,"given":"Donatella","family":"Coradduzza","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-2577","authenticated-orcid":false,"given":"Sara","family":"Cruciani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Arru","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-2142","authenticated-orcid":false,"given":"Giuseppe","family":"Garroni","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Pashchenko","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"},{"name":"Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-0255","authenticated-orcid":false,"given":"Mosab","family":"Jedea","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, Via de Crecchio 7, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4787-3776","authenticated-orcid":false,"given":"Silvia","family":"Zappavigna","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, Via de Crecchio 7, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-6091","authenticated-orcid":false,"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, Via de Crecchio 7, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evzen","family":"Amler","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague, Czech Republic"},{"name":"Student Science, s.r.o., Nar. hrdinu 279, 190 12 Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6985-4907","authenticated-orcid":false,"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0187-4968","authenticated-orcid":false,"given":"Margherita","family":"Maioli","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy"},{"name":"Center for Developmental Biology and Reprogramming (CEDEBIOR), Department of Biomedical Sciences, University of Sassari, Viale San Pietro 43\/B, 07100 Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1541-7786.MCR-13-0230","article-title":"Comparative microrna profiling of prostate carcinomas with increasing tumor stage by deep sequencing","volume":"12","author":"Hart","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","article-title":"MicroRNA expression profiling in prostate cancer","volume":"67","author":"Porkka","year":"2007","journal-title":"Cancer Res."},{"key":"ref_3","first-page":"620","article-title":"Regulators of gene expression as biomarkers for prostate cancer","volume":"2","author":"Willard","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"ref_4","first-page":"55","article-title":"Noncoding RNAs and Cancer","volume":"1","author":"Naeini","year":"2009","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/cgt.2008.8","article-title":"Modulation of miRNA activity in human cancer: A new paradigm for cancer gene therapy?","volume":"15","author":"Tong","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2013.01.004","article-title":"miRNA profiling of cancer","volume":"23","author":"Croce","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ijc.25376","article-title":"Circulating miRNAs are correlated with tumor progression in prostate cancer","volume":"128","author":"Brase","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ijc.26405","article-title":"Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease","volume":"131","author":"Selth","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cheng, H.H., Yi, H.S., Kim, Y., Kroh, E.M., Chien, J.W., Eaton, K.D., Goodman, M.T., Tait, J.F., Tewari, M., and Pritchard, C.C. (2013). Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064795"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/pros.22848","article-title":"miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression","volume":"74","author":"Corcoran","year":"2014","journal-title":"Prostate"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.29054","article-title":"Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer","volume":"136","author":"Guzel","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/jcb.26445","article-title":"The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies","volume":"119","author":"Song","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bertoli, G., Cava, C., and Castiglioni, I. (2016). MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030421"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Balzano, F., Campesi, I., Cruciani, S., Garroni, G., Bellu, E., Giudici, S.D., Angius, A., Oggiano, A., Rallo, V., and Capobianco, G. (2019). Epigenetics, Stem Cells, and Autophagy: Exploring a Path Involving miRNA. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205091"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.onc.1210809","article-title":"Widespread deregulation of microRNA expression in human prostate cancer","volume":"27","author":"Ozen","year":"2008","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1158\/0008-5472.CAN-08-0144","article-title":"Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer","volume":"68","author":"Ambs","year":"2008","journal-title":"Cancer Res."},{"key":"ref_17","first-page":"796","article-title":"MicroRNA expression profiles in the progression of prostate cancer\u2014From high-grade prostate intraepithelial neoplasia to metastasis","volume":"31","author":"Leite","year":"2013","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcp.21796","article-title":"Mechanism of growth inhibition by MicroRNA 145: The role of the IGF-I receptor signaling pathway","volume":"220","author":"Badin","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e0161491","DOI":"10.1371\/journal.pone.0161491","article-title":"A meta-analysis: Identification of common Mir-145 target genes that have similar behavior in different GEO datasets","volume":"11","author":"Pashaei","year":"2016","journal-title":"PLoS ONE"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1007\/s11033-021-06568-7","article-title":"Identification of miRNA signatures and their therapeutic potentials in prostate cancer","volume":"48","author":"Karadag","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1080\/21655979.2021.1945361","article-title":"MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1681\/ASN.2016111222","article-title":"Targeting phospholipase D4 attenuates kidney fibrosis","volume":"28","author":"Trivedi","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/BF01208639","article-title":"Increased phospholipase D activity in human breast cancer","volume":"123","author":"Uchida","year":"1997","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/brv.12592","article-title":"Phospholipase D as a key modulator of cancer progression","volume":"95","author":"Yao","year":"2020","journal-title":"Biol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/bjc.2013.250","article-title":"The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients","volume":"108","author":"Avgeris","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ijc.26064","article-title":"MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening","volume":"130","author":"Wach","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.juro.2010.10.035","article-title":"MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer","volume":"185","author":"Leite","year":"2011","journal-title":"J. Urol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Karatas, O.F., Guzel, E., Suer, I., Ekici, I.D., Caskurlu, T., Creighton, C.J., Ittmann, M., and Ozen, M. (2014). miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098675"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/pros.22499","article-title":"Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer","volume":"72","author":"Shen","year":"2012","journal-title":"Prostate"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/pros.23376","article-title":"MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method","volume":"77","author":"Xu","year":"2017","journal-title":"Prostate"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/carcin\/bgv063","article-title":"miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis","volume":"36","author":"Larne","year":"2015","journal-title":"Carcinogenesis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1158\/1078-0432.CCR-14-1566","article-title":"Identification and functional validation of reciprocal microRNA-mRNA pairings in African American prostate cancer disparities","volume":"21","author":"Wang","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.juro.2013.07.064","article-title":"Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma","volume":"191","author":"Audenet","year":"2014","journal-title":"J. Urol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43819","DOI":"10.18632\/oncotarget.6102","article-title":"Screening key microRNAs for castration-resistant prostate cancer based on miRNA\/mRNA functional synergistic network","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/pros.2990110405","article-title":"Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers","volume":"11","author":"Buttyan","year":"1987","journal-title":"Prostate"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Gao, L., Schwartzman, J., Gibbs, A., Lisac, R., Kleinschmidt, R., Wilmot, B., Bottomly, D., Coleman, I., Nelson, P., and McWeeney, S. (2013). Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063563"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/cdd.2009.117","article-title":"MiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-\u03b1 in human breast cancer cells","volume":"17","author":"Spizzo","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/onc.2015.295","article-title":"Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer","volume":"35","author":"Coarfa","year":"2016","journal-title":"Oncogene"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2017.191","article-title":"Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer","volume":"117","author":"Goto","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7150\/jca.6394","article-title":"Comprehensive microRNA profiling of prostate cancer","volume":"4","author":"Walter","year":"2013","journal-title":"J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17228","DOI":"10.1002\/jcb.28984","article-title":"miR-148-3p and miR-152-3p synergistically regulate prostate cancer progression via repressing KLF4","volume":"120","author":"Feng","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Ar\u00e1mbula-Meraz, E., Bergez-Hern\u00e1ndez, F., Leal-Le\u00f3n, E., Romo-Mart\u00ednez, E., Picos-C\u00e1rdenas, V., Luque-Ortega, F., Romero-Quintana, J., Alvarez-Arrazola, M., and Garc\u00eda-Magallanes, N. (2020). Expression of miR-148b-3p is correlated with overexpression ofbiomarkers in prostate cancer. Genet. Mol. Biol., 43.","DOI":"10.1590\/1678-4685-gmb-2018-0330"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Paunescu, I.A., Bardan, R., Marcu, A., Nitusca, D., Dema, A., Negru, S., Balacescu, O., Balacescu, L., Cumpanas, A., and Sirbu, I.O. (2019). Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer. Medicina, 55.","DOI":"10.3390\/medicina55090564"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.3390\/ijms14035239","article-title":"A cancer-indicative microRNA pattern in normal prostate tissue","volume":"14","author":"Hellwinkel","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-7-2","article-title":"Clinical implications and utility of field cancerization","volume":"7","author":"Dakubo","year":"2007","journal-title":"Cancer Cell Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0714.2004.00225.x","article-title":"A genetic progression model of oral cancer: Current evidence and clinical implications","volume":"33","author":"Braakhuis","year":"2004","journal-title":"J. Oral Pathol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1349-7006.2006.00264.x","article-title":"Development and progression of urothelial carcinoma","volume":"97","author":"Kakizoe","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_48","first-page":"8157","article-title":"Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines","volume":"15","author":"Ostadrahimi","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"30760","DOI":"10.18632\/oncotarget.8953","article-title":"Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling","volume":"7","author":"Kristensen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/0008-5472.CAN-10-2421","article-title":"Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells","volume":"71","author":"Leivonen","year":"2011","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-013-1576-z","article-title":"MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor","volume":"377","author":"Qu","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Li, X., Chen, Y.T., Josson, S., Mukhopadhyay, N.K., Kim, J., Freeman, M.R., and Huang, W.C. (2013). MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070987"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Garofalo","year":"2014","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/pros.23803","article-title":"Circulating microRNAs in plasma among men with low-grade and high-grade prostate cancer at prostate biopsy","volume":"79","author":"McDonald","year":"2019","journal-title":"Prostate"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"144963","DOI":"10.1016\/j.gene.2020.144963","article-title":"Comparative analysis of epi-miRNA expression levels in local\/locally advanced and metastatic prostate cancer patients","volume":"758","author":"Gurbuz","year":"2020","journal-title":"Gene"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Phi, L.T.H., Sari, I.N., Yang, Y.G., Lee, S.H., Jun, N., Kim, K.S., Lee, Y.K., and Kwon, H.Y. (2018). Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. Stem Cells Int., 2018.","DOI":"10.1155\/2018\/5416923"},{"key":"ref_57","first-page":"684","article-title":"Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer","volume":"4","author":"Zhang","year":"2021","journal-title":"Cancer Drug Resist."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Khan, A., Ahmed, E., Elareer, N., Junejo, K., Steinhoff, M., and Uddin, S. (2019). Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. Cells, 8.","DOI":"10.3390\/cells8080840"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e00191","DOI":"10.1042\/BSR20150025","article-title":"Human mesenchymal stem cells\u2014Current trends and future prospective","volume":"35","author":"Ullah","year":"2015","journal-title":"Biosci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1242\/dev.148270","article-title":"Prostate organogenesis: Tissue induction, hormonal regulation and cell type specification","volume":"144","author":"Toivanen","year":"2017","journal-title":"Development"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4419-7037-4_11","article-title":"Adult stem cels and their niches","volume":"695","author":"Ferraro","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/path.2478","article-title":"Prostate cancer stem cells","volume":"217","author":"Lang","year":"2009","journal-title":"J. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gupta, S., Prajapati, A., Gupta, S., and Mistry, B. (2013). Prostate stem cells in the development of benign prostate hyperplasia and prostate cancer: Emerging role and concepts. Biomed Res. Int., 2013.","DOI":"10.1155\/2013\/107954"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1634\/stemcells.2007-0309","article-title":"Characterization of adult prostatic progenitor\/stem cells exhibiting self-renewal and multilineage differentiation","volume":"26","author":"Barclay","year":"2008","journal-title":"Stem Cells"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"20130075","DOI":"10.1098\/rsfs.2013.0075","article-title":"The balance between cell cycle arrest and cell proliferation: Control by the extracellular matrix and by contact inhibition","volume":"4","author":"Goldbeter","year":"2014","journal-title":"Interface Focus"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Balzano, F., Garroni, G., Cruciani, S., Bellu, E., Dei Giudici, S., Oggiano, A., Capobianco, G., Dessole, S., Ventura, C., and Maioli, M. (2020). Behavioral Changes in Stem-Cell Potency by HepG2-Exhausted Medium. Cells, 9.","DOI":"10.3390\/cells9081890"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Garroni, G., Balzano, F., Cruciani, S., Pala, R., Coradduzza, D., Azara, E., Bellu, E., Cossu, M.L., Ginesu, G.C., and Carru, C. (2021). Adipo-derived stem cell features and mcf-7. Cells, 10.","DOI":"10.3390\/cells10071754"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2004-1123","article-title":"A System for Studying Epithelial-Stromal Interactions Reveals Distinct Inductive Abilities of Stromal Cells from Benign Prostatic Hyperplasia and Prostate Cancer","volume":"146","author":"Barclay","year":"2005","journal-title":"Endocrinology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10409238.2015.1117054","article-title":"Dysregulation of microRNA biogenesis machinery in cancer","volume":"51","author":"Hata","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-94-007-6621-1_18","article-title":"Regulation of Stem Cell Populations by microRNAs","volume":"786","author":"Mathieu","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1177\/1535370215584935","article-title":"MicroRNAs targeting prostate cancer stem cells","volume":"240","author":"Fang","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2009.02.038","article-title":"MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells","volume":"137","author":"Xu","year":"2009","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3892\/or.2012.2015","article-title":"miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells","volume":"28","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3892\/ol.2021.13066","article-title":"miR-148a, miR-152 and miR-200b promote prostate cancer metastasis by targeting DNMT1 and PTEN expression","volume":"22","author":"Gurbuz","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/pcan.2010.32","article-title":"miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression","volume":"13","author":"Murata","year":"2010","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.2147\/OTT.S248925","article-title":"miR-148a Regulates the Stem Cell-Like Side Populations Distribution by Affecting the Expression of ACVR1 in Esophageal Squamous Cell Carcinoma","volume":"13","author":"Tan","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12894-020-00617-2","article-title":"MiR-185 inhibits prostate cancer angiogenesis induced by the nodal\/ALK4 pathway","volume":"20","author":"Li","year":"2020","journal-title":"BMC Urol."},{"key":"ref_79","first-page":"2774","article-title":"MiR-185 regulates the growth of osteosarcoma cells via targeting Hexokinase 2","volume":"20","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1626\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:11:41Z","timestamp":1760134301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":79,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031626"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031626","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,30]]}}}